Parainfluenza Virus Infection - Epidemiology Forecast - 2034

Parainfluenza Virus Infection - Epidemiology Forecast - 2034

Key Highlights

The Parainfluenza virus infection epidemiology is projected to witness consistent growth throughout the forecast period (2024–2034). The incident cases of parainfluenza virus infection in the 7MM is expected to increase, driven by increasing Incident population.

DelveInsight’s analyst projects that the total Incident Cases of Parainfluenza Virus in 7MM were approximately 2,709,923 in 2023 and these cases are further expected to increase during the forecasted period (2024–2034).

In 2023, among the 7MM, the US accounted for the highest Incident cases of PIV, representing 54% of the total cases, followed by Japan (10%), and Germany and Spain (9%). Analysis by DelveInsight’s experts indicates that the overall Incident cases of PIV are expected to rise in the coming years.

As per DelveInsight’s estimates, Japan accounted for nearly 262 thousand of the total Incident Cases of PIV in the 7MM in 2023.

DelveInsight’s “Parainfluenza virus infection (PIV) – Epidemiology Forecast – 2034” report delivers an in-depth understanding of Parainfluenza virus infection, historical and forecasted epidemiology of Parainfluenza virus infection in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Geography Covered

The United States

EU4 (Germany, France, Italy, and Spain) and the United Kingdom

Japan

Study Period: 2020–2034

Parainfluenza virus infection Disease Understanding

Parainfluenza virus infection Overview

Parainfluenza virus (PIV) infection is a respiratory illness caused by one of four types of parainfluenza viruses: PIV-1, PIV-2, PIV-3, and PIV-4. These viruses belong to the Paramyxoviridae family and primarily affect the respiratory tract, leading to various respiratory infections such as the common cold, croup, bronchiolitis, and pneumonia.

The causes of PIV infection involve transmission through respiratory droplets expelled when an infected person coughs, sneezes, or talks. Additionally, indirect transmission can occur through contact with contaminated surfaces.

Symptoms of PIV infection vary depending on the type and severity of the illness but commonly include symptoms of the common cold such as runny nose, cough, sore throat, and fever. In more severe cases, symptoms may include difficulty breathing, wheezing, and chest pain.

Parainfluenza virus infection Diagnosis

Diagnosis of PIV infection involves clinical evaluation, including a review of symptoms and medical history, as well as laboratory tests such as PCR or antigen detection tests on respiratory specimens. These tests can detect the presence of parainfluenza virus genetic material or antigens. Differential diagnosis may be necessary to distinguish PIV infection from other respiratory viruses with similar symptoms.

Further details related to diagnosis are provided in the report…

Parainfluenza virus infection Epidemiology

For the purpose of designing the patient-based model for the PIV epidemiology chapter in the report provides historical as well as forecasted epidemiology segmented by, Total Incident Cases of Parainfluenza virus infection, Serotype-specific Incident Cases of Parainfluenza Virus, Gender-specific Incident Cases of Parainfluenza Virus, and Age-specific Incident Cases of Parainfluenza Virus in the 7MM covering, the United States, EU4 countries (Germany, France, Italy, and Spain), United Kingdom, and Japan from 2020 to 2034.

According to DelveInsight estimations, 2,709,923 Cases of Parainfluenza virus infection were found in 2023 in the 7MM.

As per DelveInsight’s estimations, the total number of incident cases of parainfluenza virus in the United States were 1,456,399 in 2023 and are projected to increase during the forecast period.

According to DelveInsight’s estimates, the total Incident Cases of parainfluenza virus infection in EU4 and the UK were found to be 991,115 in 2023. The highest proportion of parainfluenza virus infection cases was reported in Spain among the EU4 countries, while the least number of cases was found in the UK.

The estimates show the number of parainfluenza virus infection cases in Japan was found to be approximately 262,409 in 2023, which is estimated to increase by 2034.

KOL Views

To gaze into the epidemiology insights of the real world, we take KOLs and SMEs’ opinions working in the domain through primary research to fill the data gaps and validate our secondary research on disease prevalence.

DelveInsight’s analysts connected with 20+ KOLs to gather insights; however, interviews were conducted with 10+ KOLs in the 7MM. Centers such as Department of Emergency Medicine, State University of New York at Stony Brook Health Sciences Center, US, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, US, Comprehensive Heart Failure Centre Würzburg and Department of Internal Medicine, University and University Hospital Würzburg, Germany, Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan were contacted. Their opinion helps understand and validate current disease prevalence, gender involved with the disease, diagnosis rate, and diagnostic criteria.

Scope of the Report

The report covers a segment of key events, an executive summary, descriptive overview of Parainfluenza virus infection, explaining its causes, signs and symptoms, and currently available diagnostic algorithms and guidelines.

Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of diagnosis rate, disease progression, and diagnosis guidelines.

The report provides an edge for understanding trends, expert insights/KOL views, and patient journeys in the 7MM.

A detailed review of current challenges in establishing the diagnosis.

Parainfluenza virus infection Report Insights

Patient Population

Country-wise Epidemiology Distribution

Total Incident Cases of PIV Infection in the US

Serotype-Specific Incident Cases of PIV Infection in the US

Gender-specific Incident Cases of PIV Infection in the US

Age-specific Incident Cases of PIV Infection in the US

Parainfluenza virus infection Report Key Strengths

11 years Forecast

The 7MM Coverage

Parainfluenza virus infection Epidemiology Segmentation

Parainfluenza virus infection Report Assessment

Current Diagnostic Practices Patient Segmentation

Epidemiology Insights

What are the disease risk, burdens, and unmet needs of Parainfluenza virus infection? What will be the growth opportunities across the 7MM concerning the patient population of Parainfluenza virus infection?

What is the historical and forecasted Parainfluenza virus infection patient pool in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan?

Why is the diagnosed prevalent cases of PIV in Japan lower than the US?

Which country has a high patient share for PIV?

Reasons to Buy

Insights on patient burden/disease, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.

To understand the Parainfluenza virus infection prevalence cases in varying geographies over the coming years.

A detailed overview of Gender and Age Grade-specific diagnosed prevalence of PIV, along with diagnosed prevalence of PIV Based on severity of airflow limitation and diagnosed prevalence of PIV based on symptoms and exacerbation history.

To understand the perspective of key opinion leaders around the current challenges with establishing the diagnosis options.

Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.

Frequently Asked Questions

1. What is the forecast period covered in the report?

The Parainfluenza virus infection Epidemiology report for the 7MM covers the forecast period from 2024 to 2034, providing a projection of epidemiology dynamics and trends during this timeframe.

2. Out of all EU4 countries and the UK, which country had the highest population of Parainfluenza virus infection (PIV) cases in 2023?

The highest cases of Parainfluenza virus infection was found in the Germany among EU4 and the UK in 2023.

3. How is epidemiological data collected and analyzed for forecasting purposes?

Epidemiological data is collected through surveys, clinical studies, health records, and other sources. It is then analyzed to calculate disease rates, identify trends, and project future disease burdens using mathematical models.

4. Out of all 7MM countries, which country had the highest population of Parainfluenza virus infection (PIV) cases in 2023?

The highest cases of Parainfluenza virus infection were found in the US among the 7MM in 2023.